Alvogen Korea Co., Ltd. manufactures and sells pharmaceutical products in South Korea and internationally. The company offers approximately 200 products. It provides anti-obesity treatment products, such as Furing and Oliet; products in various therapeutic categories, such as nephrology, cardiology, urology, oncology, neurology, endocrinology, and immunology; and incrementally modified and anti-virus drugs. The company offers its products through general hospitals and clinics in various dosage forms comprising tablets, coated tablets, capsules, granules, powders, and sachets. It is also involved in the research and development of fixed dose combination or controlled release, oncology, and CNS treatment drugs. The company was formerly known as Kunwha Pharmaceutical Co., Ltd. and changed its name to Alvogen Korea Co., Ltd. in June 2015. The company was founded in 1958 and is headquartered in Seoul, South Korea. Alvogen Korea Co., Ltd. is a subsidiary of Alvogen Korea Holdings Ltd.